List view / Grid view




Advancing novel biotherapeutics based on synthetic biology

22 September 2022 | By

Researchers at Synlogic are clearing the path for a new class of medicine – biotherapeutics based on synthetic biology, called synthetic biotics, which are created by programming or engineering bacteria to metabolise or secrete well-validated targets of disease pathophysiology. In this article, Dr Caroline Kurtz, Chief Development Officer at Synlogic, discusses how synthetic…


LDC enters new drug discovery partnership with Roche

21 January 2016 | By Victoria White

The Lead Discovery Centre (LDC) and Roche have announced that they are to collaborate to identify and leverage innovative therapeutic opportunities that address diseases of unmet medical need...


Roche to acquire Kapa Biosystems

19 August 2015 | By Victoria White

Roche has signed a definitive agreement to acquire Kapa Biosystems, strengthening Roche's next-generation sequencing product offerings...